Thema
Letter
304
Comment
222
Journal Article
126
autoimmune diseases
126
COVID-19
114
epidemiology
98
Antirheumatic Agents
91
Research Support, Non-U.S. Gov't
90
inflammation
77
biological therapy
74
COVID-19 Vaccines
72
Covid-19
71
vaccination
71
antirheumatic agents
70
4QWG6N8QKH
64
Hydroxychloroquine
64
hydroxychloroquine
61
arthritis
54
lupus erythematosus, systemic
42
Glucocorticoids
41
cytokines
40
Antibodies, Viral
37
rheumatoid
35
therapeutics
35
glucocorticoids
34
I031V2H011
33
Research Support, N.I.H., Extramural
33
immune system diseases
33
rituximab
33
tocilizumab
33
Rituximab
31
4F4X42SYQ6
30
systemic
29
Antibodies, Monoclonal, Humanized
24
Immunosuppressive Agents
24
arthritis, rheumatoid
24
health care
24
health services research
24
lupus erythematosus
22
systemic vasculitis
22
autoimmunity
20
outcome assessment
20
BNT162 Vaccine
17
N38TVC63NU
16
Vaccination
16
Tumor Necrosis Factor Inhibitors
15
Janus Kinase Inhibitors
13
Multicenter Study
13
Antimalarials
12
Colchicine
12
mehr ...